MedTrace Logo

Treatment With the Evoke System for Facial and Submental Laxity

NCT04719013 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2023-03-31

Study results available
· View outcomes & findings →

Summary

The aim of the study is to evaluate the efficacy, patient comfort, and patient satisfaction after Evoke treatment for face and submental area

Conditions

  • Laxity; Skin

Interventions

DEVICE

Evoke radiofrequency device

Enrolled subjects will undergo up to 3 successive bi-weekly (every 2 weeks) treatments,

Sponsors & Collaborators

  • InMode MD Ltd.

    lead INDUSTRY

Principal Investigators

  • Rodney Rohrich, MD · Dallas Plastic Surgery Institute

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-07-15
Completion
2022-07-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04719013 on ClinicalTrials.gov